Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Canadian Stocks Hedge Funds Like

Page 1 of 2

The Canadian market has had a decent year so far, with the benchmark S&P/TSX Composite Index gaining more than 12% for the year. While the sharp pullback in oil prices over the past two years had a negative impact on the Canadian economy, the outlook for oil has improved somewhat this year, providing Canadian equities with a much-needed rebound. However, the index still remains below its 2014 highs.

In this article, we’ll take a look at the five Canadian stocks that the hedge funds in our database like the most, which are Valeant Pharmaceuticals International Inc. (NYSE:VRX), Barrick Gold Corporation (USA) (NYSE:ABX), Potash Corporation of Saskatchewan (USA) (NYSE:POT), Canadian Pacific Railway Limited (USA) (NYSE:CP) and Kinross Gold Corporation (USA) (NYSE:KGC). We’ll also analyze how these stocks have performed and what they may have in store for investors.

At Insider Monkey, we track around 750 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

stock, trading, market, trader, traders, investor, investment, screen, bank, banking, share, broker, graph, business, chart, index, data, information, capital, team, money,

Matej Kastelic/Shutterstock.com

A total of 31 funds that we track held $722.9 million worth of Kinross Gold Corporation (USA) (NYSE:KGC) shares at the end of the June quarter, accounting for 11.90% of the company’s outstanding shares. At the end of the March quarter, 28 funds held approximately $417.94 million worth of the company’s shares. Kinross Gold Corporation (USA) (NYSE:KGC) announced earlier this month that it had repaid $250 million in senior notes that were due September 1. With the repayment, the company now has no other debt maturities until 2020. Kinross believes that its strong balance sheet and liquidity position provides it with the financial flexibility needed to fund organic growth opportunities.

Follow Kinross Gold Corp (NYSE:KGC)
Trade (NYSE:KGC) Now!

Among the hedge funds in our system, 32 held $946.90 million worth of Potash Corporation of Saskatchewan (USA) (NYSE:POT) shares at the end of the June quarter, up from 23 funds with $793.78 million worth of Potash Corporation shares at the end of March. The collapse of the Belarusian Potash Company in the summer of 2013 completely changed the dynamics of the potash market. Given the increasing competition in the market, producers have been looking to consolidate. Last year, Potash Corporation of Saskatchewan (USA) (NYSE:POT) launched a hostile bid for its German rival K+S, though it failed to take over the German potash producer. This week, Potash and Agrium Inc. (NYSE:AGU) announced a merger that would create a global leader in the fertilizer industry. According to the terms of the merger agreement, Potash shareholders will receive 0.40 common shares of the new company for each common share of Potash that they own, while Agrium shareholders will receive 2.230 common shares of the new company for each common share of Agrium that they own.

Follow Potash Corp Saskatchewan Inc (NYSE:POT)
Trade (NYSE:POT) Now!

We’ll check out hedge funds’ three favorite Canadian stocks on the next page, eh?

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!